The Obesity Susceptibility Gene Carboxypeptidase E Links FoxO1 Signaling in Hypothalamic Pro–opiomelanocortin Neurons with Regulation of Food Intake

[1]  B. Lowell,et al.  Monitoring FoxO1 Localization in Chemically Identified Neurons , 2008, The Journal of Neuroscience.

[2]  G. Bray.  Lifestyle and pharmacological approaches to weight loss: efficacy and safety. , 2008, The Journal of clinical endocrinology and metabolism.

[3]  Alexander S. Banks,et al.  SirT1 gain of function increases energy efficiency and prevents diabetes in mice. , 2008, Cell metabolism.

[4]  R. Rodriguiz,et al.  Absence of carboxypeptidase E leads to adult hippocampal neuronal degeneration and memory deficits , 2008, Hippocampus.

[5]  J. Shiraishi,et al.  Effects of N-terminal fragments of β-endorphin on feeding in chicks , 2008, Neuroscience Letters.

[6]  D. Good,et al.  Nescient helix-loop-helix 2 interacts with signal transducer and activator of transcription 3 to regulate transcription of prohormone convertase 1/3. , 2008, Molecular endocrinology.

[7]  A. Pocai,et al.  Leptin controls adipose tissue lipogenesis via central, STAT3–independent mechanisms , 2008, Nature Medicine.

[8]  A. Husch,et al.  PDK1 deficiency in POMC-expressing cells reveals FOXO1-dependent and -independent pathways in control of energy homeostasis and stress response. , 2008, Cell metabolism.

[9]  V. Hruby,et al.  Effects of selective modulation of the central melanocortin-3-receptor on food intake and hypothalamic POMC expression , 2008, Peptides.

[10]  A. Trenkle,et al.  Prolonged, moderate nutrient restriction in beef cattle results in persistently elevated circulating ghrelin concentrations. , 2008, Journal of animal science.

[11]  H. Münzberg,et al.  Enhanced leptin-stimulated Pi3k activation in the CNS promotes white adipose tissue transdifferentiation. , 2007, Cell metabolism.

[12]  R. DePinho,et al.  A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. , 2007, The Journal of clinical investigation.

[13]  E. Nillni.  Regulation of prohormone convertases in hypothalamic neurons: implications for prothyrotropin-releasing hormone and proopiomelanocortin. , 2007, Endocrinology.

[14]  Yonghong Xiao,et al.  FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis , 2007, Cell.

[15]  B. Neel,et al.  Neuronal PTP1B regulates body weight, adiposity and leptin action , 2006, Nature Medicine.

[16]  F. Ashcroft,et al.  Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity. , 2006, The Journal of clinical investigation.

[17]  J. Brüning,et al.  Central insulin action in energy and glucose homeostasis. , 2006, The Journal of clinical investigation.

[18]  Min-Seon Kim,et al.  Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis , 2006, Nature Neuroscience.

[19]  N. Gekakis,et al.  Obesity, hyperphagia and increased metabolic efficiency in Pc1 mutant mice. , 2006, Human molecular genetics.

[20]  G. Barsh,et al.  Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake , 2006, Nature Medicine.

[21]  Xiaorong Zhu,et al.  Agouti-related protein is posttranslationally cleaved by proprotein convertase 1 to generate agouti-related protein (AGRP)83-132: interaction between AGRP83-132 and melanocortin receptors cannot be influenced by syndecan-3. , 2006, Endocrinology.

[22]  S. Heymsfield,et al.  Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. , 2005, The Journal of clinical investigation.

[23]  D. Accili,et al.  FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. , 2005, Cell metabolism.

[24]  R. Rodriguiz,et al.  The carboxypeptidase E knockout mouse exhibits endocrinological and behavioral deficits. , 2004, Endocrinology.

[25]  E. Nillni,et al.  Regulation of hypothalamic prohormone convertases 1 and 2 and effects on processing of prothyrotropin-releasing hormone. , 2004, The Journal of clinical investigation.

[26]  T. Williams,et al.  Behavioral and physiologic responses to caloric restriction in mice , 2004, Physiology & Behavior.

[27]  B. Lowell,et al.  Leptin Receptor Signaling in POMC Neurons Is Required for Normal Body Weight Homeostasis , 2004, Neuron.

[28]  D. Accili,et al.  FoxOs at the Crossroads of Cellular Metabolism, Differentiation, and Transformation , 2004, Cell.

[29]  D. Vishnuvardhan,et al.  Obliteration of α‐melanocyte‐stimulating hormone derived from POMC in pituitary and brains of PC2‐deficient mice , 2003, Journal of neurochemistry.

[30]  P. Morgan,et al.  Precursor-protein convertase 1 gene expression in the mouse hypothalamus: differential regulation by ob gene mutation, energy deficit and administration of leptin, and coexpression with prepro-orexin , 2003, Neuroscience.

[31]  E. Air,et al.  The Catabolic Action of Insulin in the Brain Is Mediated by Melanocortins , 2002, The Journal of Neuroscience.

[32]  Chunling Zhang,et al.  Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Levine,et al.  Injection of alpha-MSH, but not beta-endorphin, into the PVN decreases POMC gene expression in the ARC. , 2002, Neuroreport.

[34]  R. G. Allen,et al.  Altered Processing of Pro-Orphanin FQ/Nociceptin and Pro-Opiomelanocortin-Derived Peptides in the Brains of Mice Expressing Defective Prohormone Convertase 2 , 2001, The Journal of Neuroscience.

[35]  M. Permutt,et al.  Missense polymorphism in the human carboxypeptidase E gene alters enzymatic activity , 2001, Human mutation.

[36]  Haiyang Li,et al.  Identification of peptides from brain and pituitary of Cpefat/Cpefat mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  L. Orci,et al.  Severe Defect in Proglucagon Processing in Islet A-cells of Prohormone Convertase 2 Null Mice* , 2001, The Journal of Biological Chemistry.

[38]  A. Polonskaia,et al.  Impaired Prohormone Convertases inCpe fat/Cpe fat Mice* , 2001, The Journal of Biological Chemistry.

[39]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[40]  Papadopoulos,et al.  Endogenous α‐MSH modulates the Hypothalamic‐Pituitary‐Adrenal Response to the Cytokine Interleukin‐1β , 1999, Journal of neuroendocrinology.

[41]  A. Viale,et al.  Cellular Localization and Role of Prohormone Convertases in the Processing of Pro-melanin Concentrating Hormone in Mammals* , 1999, The Journal of Biological Chemistry.

[42]  B. Rist,et al.  Role of prohormone convertases in pro-neuropeptide Y processing: coexpression and in vitro kinetic investigations. , 1997, Biochemistry.

[43]  S. O’Rahilly,et al.  Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene , 1997, Nature Genetics.

[44]  M. Narazaki,et al.  Overlapping and distinct signals through leptin receptor (OB‐R) and a closely related cytokine signal transducer, gp130 , 1997, FEBS letters.

[45]  M. Castro,et al.  Procorticotrophin releasing hormone is endoproteolytically processed by the prohormone convertase PC2 but not by PC1 within stably transfected CHO-K1 cells. , 1996, Biochemical Society Transactions.

[46]  D. Steiner,et al.  Internal cleavage of the inhibitory 7B2 carboxyl-terminal peptide by PC2: a potential mechanism for its inactivation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Naggert,et al.  Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity , 1995, Nature Genetics.

[48]  R. Leibel,et al.  Changes in energy expenditure resulting from altered body weight. , 1995, The New England journal of medicine.

[49]  S. Wardlaw,et al.  Effect of opioid antagonism on β-endorphin processing and proopiomelanocortin-peptide release in the hypothalamus , 1994, Brain Research.

[50]  S. P. Grossman,et al.  Chronic intrahypothalamic insulin infusion in the rat: Behavioral specificity , 1993, Physiology & Behavior.

[51]  R. Young,et al.  Proopiomelanocortin is the predominant adrenocorticotropin-related peptide in human cerebrospinal fluid. , 1993, The Journal of clinical endocrinology and metabolism.

[52]  N. Seidah,et al.  PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[53]  S. Wardlaw.  Regulation of β-endorphin, corticotropin-like intermediate lobe peptide, and α-melanotropin-stimulating hormone in the hypothalamus by testosterone , 1986 .

[54]  P. Nicolas,et al.  Beta-endorphin-(1-27) is a naturally occurring antagonist to etorphine-induced analgesia. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[55]  S. Woods,et al.  Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons , 1979, Nature.

[56]  D. Yach,et al.  Epidemiologic and economic consequences of the global epidemics of obesity and diabetes , 2006, Nature Medicine.

[57]  L. Gordon,et al.  EFFICACY AND SAFETY OF , 2004 .

[58]  D. Accili,et al.  The forkhead transcription factor Foxo1 regulates adipocyte differentiation. , 2003, Developmental cell.

[59]  I. Sartori.  Changes in Energy Expenditure Resulting from Altered Body Weight , 1996 .

[60]  S. Wardlaw.  Regulation of beta-endorphin, corticotropin-like intermediate lobe peptide, and alpha-melanotropin-stimulating hormone in the hypothalamus by testosterone. , 1986, Endocrinology.

[61]  L. E. Pritchard,et al.  Printed in U.S.A. Copyright © 2007 by The Endocrine Society doi: 10.1210/en.2006-1686 Minireview: Neuropeptide Processing and Its Impact on , 2022 .